Clinical Studies
Patients benefit from the Eye Institute’s involvement in numerous Federal and Drug Administration (FDA) national clinical research trials. Patients who qualify can take advantage of new cutting-edge therapies at no cost. Providing access to these national studies keeps the community updated on the latest medical and surgical advances in eye care.
-
Choroidal Neovascularization
-
Age-Related Macular Degeneration
-
Pigment Epithelial Detachment
-
Focal Vitreomacular Adhesion
-
Central Retinal Vein Occlusion
-
Diabetic Macular Edema
-
Dry Eyes
-
Glaucoma